Fig. 2From: Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesionsCase K22. a Normal breast tissue, b primary breast invasive lobular carcinoma showing loose trabecular growth with CDH1 p.Q264*mutation, and c pleural effusion containing metastatic cancer cells with CDH1 p.Q264*, ERBB2 p.S310F, CBFB p.X27_splice and TP53 p.R248Q mutationsBack to article page